A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this phase I clinical study was to evaluate the safety and tolerability of
JS107 monotherapy and combination with Toripalimab in patients with Advanced pancreatic
cancer.